Guidelines for Counseling Postmenopausal Women about Preventive Hormone Therapy
Excerpt
The following are guidelines for counseling asymptomatic postmenopausal women about using hormone therapy to prevent disease and to prolong life. Hormone therapy is effective for treating many of the symptoms associated with menopause. When treating menopausal symptoms, hormones should be given for a limited time (1 to 5 years). Counseling about the risks and benefits of long-term hormone therapy may begin during the period when a woman is being treated for menopausal symptoms, but decisions regarding these two uses of hormone therapy should be made separately.
The hormone regimens considered in these guidelines include unopposed estrogen therapy and estrogen plus
Article and Author Information
-
↵* These guidelines were authored by Deborah Grady, MD, MPH; Steven R. Cummings, MD; Diana Petitti, MD; Susan M. Rubin, MPH; and Anne-Marie Audet, MD, and were developed for the Health and Public Policy Committee by the Clinical Efficacy Assessment Subcommittee: Harold C. Sox, Jr., MD, Chair; Philip M. Gold, MD; Edward J. Huth, MD; Ernest L. Mazzaferri, MD; Albert G. Mulley, Jr., MD; and George E. Thibault, MD. Members of the Health and Public Policy Committee were: Clifton R. Cleaveland, MD, Chair; Christine K. Cassel, MD; David J. Gullen, MD; Harold C. Sox, Jr., MD; Quentin D. Young, MD; Robert A. Berenson, MD; John M. Eisenberg, MD; Woodrow A. Myers, Jr., MD; Cecil O. Samuelson, Jr., MD; Steven A. Schroeder, MD; and Gerald E. Thomson, MD. The guidelines were approved by the Board of Regents on 23 March 1992.
-
Requests for Reprints: Linda Johnson White, Director, Department of Scientific Policy, American College of Physicians, Independence Mall West, Sixth Street at Race, Philadelphia, PA 19106-1572.
- © 1992 American College of Physicians
RSS Feeds









